Top Health Care Stocks
Health care stocks were slightly higher with the NYSE Health Care Sector Index climbing about 0.1% and shares of health care companies in the S&P 500 advancing about 0.2% as a group.
In company news, Heat Biologics ( HTBX ) rallied Monday after the biotech company today presented positive immunological data on its HS-410 drug candidate in certain forms of bladder cancer.
According to the company, one of the patients participating in the Phase I trial showed a 70-fold rise in CD8+ "killer" T cell after six weeks of HS-140 treatment following surgery and growing to 750-fold increase after 21 weeks of treatment.
The patient remains disease-free, HTBX said. A second patient experienced a non-specific immune infiltrate after seven weeks although a repeat biopsy at 13 weeks showed no further increase in the immune infiltrate.
HTBX shares were up nearly 42% at $5.78 each, easing slightly from a session high at $6.18 a share. The stock has traded within a 52-week range of $3.60 to $8.50 a share, dropping about 48% over the past 12 months prior to today's surge.
In other sector news,
(+) ATNM, Seeks pre-Investigational New Drug application meeting with FDA for its lomab-B drug candidate ahead of the start of Phase III testing of the bone-marrow drug administered before transplants in patients with certain forms of leukemia.
(-) MSTX, Chief Operating Officer Patrick Keran announces plans to leave the company by Feb. 28. The company did not immediately name a successor.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.